Antidote Competitors and Similar CompaniesClear all

Antidote's competitors and similar companies include Nova Pharma Solutions, International Isotopes, Exco InTouch and Banner Life Sciences.

	Antidote Antidote Technologies (formerly known as TrialReach) is a digital health company that bridging the gap between medical research and the people who need it.	Nova Pharma Solutions Nova Pharma Solution is a provider of engineering solutions for the pharmaceutical and biotechnology sectors.	International Isotopes International Isotopes develops and deploys technological solutions for radiology-related treatments.	Exco InTouch Exco InTouch is the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers	Banner Life Sciences Banner Life Sciences™ is a uniquely innovative and entrepreneurial specialty pharmaceutical company.
Founding Date	Founding Date 2010	Founding Date 2015	Founding Date 1995	Founding Date 2004	Founding Date 1994
Type	Type Private	Type Private	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare clinical research clinics healthtech pharma	Tags Healthcare biotech clinical research healthtech pharma	Tags Healthcare clinics healthtech pharma	Tags Healthcare clinical research clinics data collection healthtech hospitals pharma	Tags Healthcare clinical research clinics life sciences pharma
Locations	Locations London, GB HQ New York, US	Locations Subang Jaya, MY HQ	Locations Idaho Falls, US HQ	Locations Edwalton, GB HQ Victoria, CA Nottingham, GB Morrisville, US	Locations High Point, US HQ
Employees	Employees 365% decrease	Employees 24	Employees 3517% increase	Employees 1487% increase	Employees 323% decrease
Financial
Revenue (est.)	Revenue (est.) £7.8m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) $13.1m (FY, 2025)	Revenue (est.) £22.6m (FY, 2017)	Revenue (est.) N/A
Cost of goods	Cost of goods £3.7m (FY, 2021)	Cost of goods N/A	Cost of goods $5.4m (FY, 2025)	Cost of goods £8.4m (FY, 2017)	Cost of goods N/A
Gross profit	Gross profit £4.1m (FY, 2021)	Gross profit N/A	Gross profit $7.7m (FY, 2025)	Gross profit £14.2m (FY, 2017)	Gross profit N/A
Net income	Net income (£1.5m) (FY, 2021)	Net income N/A	Net income ($908k) (FY, 2025)	Net income £4.3m (FY, 2017)	Net income N/A
Funding
Total funding raised	Total funding raised $ 40.9m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 9.7m	Total funding raised N/A